Ana Vivancos
Principal Investigator
Oncology
Vall d'Hebron Institut d’Oncologia
Spain
Biography
"Dr. Ana Vivancos is currently working as a Principal Investigator, Cancer Genomics Group in the Department of Oncology, Vall d'Hebron Institute of Oncology , Spain. His research interests includes Molecular Biology, Biochemistry, Cancer & Genomics. she is serving as an editorial member and reviewer of several international reputed journals. Dr. Ana Vivancos is the member of many international affiliations.She has successfully completed his Administrative responsibilities. she has authored of many research articles/books related to Molecular Biology, Biochemistry, Cancer, Genomics. "
Research Interest
Molecular Biology, Biochemistry, Cancer, Genomics
Publications
-
Pérez-Alea M, Vivancos A, Caratú G, Matito J, Ferrer B, Hernandez-Losa J, Cortés J, Muñoz E, Garcia-Patos V, Recio JA. Genetic profile of GNAQ-mutated blue melanocytic neoplasms reveals mutations in genes linked to genomic instability and the PI3K pathway. Oncotarget. 2016 May 10;7(19):28086-95.
-
Vivancos A, Caratú G, Matito J, Muñoz E, Ferrer B, Hernández-Losa J, Bodet D, Pérez-Alea M, Cortés J, Garcia-Patos V, Recio JA. Genetic evolution of nevus of Ota reveals clonal heterogeneity acquiring BAP1 and TP53 mutations. Pigment Cell Melanoma Res. 2016 Mar;29(2):247-53.
-
Arqués O, Chicote I, Puig I, Tenbaum SP, Argilés G, Dienstmann R, Fernández N, Caratù G, Matito J, Silberschmidt D, Rodon J, Landolfi S, Prat A, EspÃn E, Charco R, Nuciforo P, Vivancos A, Shao W, Tabernero J, Palmer HG. Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer. Clin Cancer Res. 2016 Feb 1;22(3):644-56.
